| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01066061 |
| P8608 | Fatcat ID | release_edbex3ziqbbu3pns2s4lfl7iua |
| P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/BF01066061.pdf |
| http://link.springer.com/article/10.1007/BF01066061/fulltext.html | ||
| http://link.springer.com/content/pdf/10.1007/BF01066061 | ||
| P698 | PubMed publication ID | 349132 |
| P2093 | author name string | W. J. Jusko | |
| P2860 | cites work | Cancer Research | Q326097 |
| Drug Metabolism and Disposition | Q1261140 | ||
| Journal of Pharmacology and Experimental Therapeutics | Q1500272 | ||
| Pharmacological Reviews | Q2085079 | ||
| Annals of the New York Academy of Sciences | Q2431664 | ||
| WHO Chronicle | Q21157814 | ||
| Effects of tobacco smoke on biological systems | Q26344310 | ||
| Annals of clinical research | Q27709013 | ||
| Electron-transfer mechanism associated with fatty acid desaturation catalyzed by liver microsomes | Q28240881 | ||
| High-pressure liquid chromatography analysis of benzo(a)pyrene metabolism by microsomal enzymes from rhesus liver and lung | Q28325296 | ||
| Blood carbon monoxide levels as a function of daily cigarette consumption and physical activity | Q33573622 | ||
| POLONIUM-210: A VOLATILE RADIOELEMENT IN CIGARETTES. | Q34255785 | ||
| The effects of age and liver disease on the disposition and elimination of diazepam in adult man | Q34473755 | ||
| The influence of smoking on the intersubject variation in pentazocine elimination | Q34515204 | ||
| Decreased theophylline half-life in cigarette smokers | Q34518443 | ||
| Effect of smoking on theophylline disposition | Q34534103 | ||
| Delta-9-Tetrahydrocannabinol: Metabolism and Disposition in Long-Term Marihuana Smokers | Q70516837 | ||
| Nicotine and some carcinogens in special reference to the hepatic drug-metabolizing enzymes | Q71095723 | ||
| Effect of cigarette smoking on diuresis induced by furosemide | Q71790768 | ||
| Cigarette smoking: stimulatory effect on metabolism of 3,4-benzpyrene by enzymes in human placenta | Q72033705 | ||
| Retention of Cigarette Smoke Components in Human Lungs | Q72127660 | ||
| The hemodynamic effects of propranolol hydrochloride after smoking | Q72305479 | ||
| Effect of nicotine on the mobilization of free fatty acids from adipose tissue in vitro | Q72391135 | ||
| Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women | Q72538618 | ||
| Stimulatory effect of nicotine on the metabolism of meprobamate | Q72907567 | ||
| Controlled measurement of smoke-particle retention in the respiratory tract | Q79021963 | ||
| Some effects of nicotine and smoking on metabolic functions | Q79054687 | ||
| Excretion of thiocyanates in urine of smokers | Q79378194 | ||
| A simple test for exposure to polycyclic hydrocarbons | Q93727938 | ||
| Lowering of the activity of hepatic benzopyrene-hydroxylase in vivo after carbon monoxide inhalation | Q93808243 | ||
| Proceedings: Effects of chronic and acute cannabis treatment upon thiopentone anaesthesia in rabbits | Q95790074 | ||
| Aging and ethanol metabolism | Q67548911 | ||
| Phenobarbital-induced drug metabolism in man | Q67553037 | ||
| Development of mechanisms for drug excretion | Q67561633 | ||
| Influence of 3,4-benzo(a)pyrene on warfarin hypoprothrombinemia and disposition in the rat | Q67730932 | ||
| Smoking habits and blood carbon monoxide levels | Q67778093 | ||
| Marijuana | Q67795094 | ||
| Gas chromatographic quantitation of polynuclear aromatic hydrocarbons in tobacco smoke | Q67824399 | ||
| Comparison of the hydroxylation of zoxazolamine and benzo[a]pyrene in human placenta: effect of cigarette smoking | Q67832339 | ||
| Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat | Q67851183 | ||
| Effect of smoking and nicotine on adrenocortical secretion | Q68573477 | ||
| Alteration of enzyme activity in rat liver following the acute and chronic administration of nicotine | Q68744798 | ||
| Cigarette smoking and serum chemistry tests | Q68830457 | ||
| Effect of exposure to cigarette smoke on the metabolism of benzo6a9pyrene and acetophenetidin by lung and intestine of rats | Q69399285 | ||
| Cadmium accumulation in man: Influence of smoking, occupation, alcoholic habit and disease | Q69406546 | ||
| Interactions of chronic and acute 1 -tetrahydrocannabinol pretreatment with zoxazolamine and barbiturates | Q69477590 | ||
| Decreased clinical efficacy of propoxyphene in cigarette smokers | Q69499142 | ||
| Smoking, drinking and non-narcotic analgesic habits in an occupational group | Q69567798 | ||
| Stimulation of liver detoxication enzymes by dietary cadmium acetate | Q69645326 | ||
| Effect of cigarette smoking on phenacetin metabolism | Q69729603 | ||
| Bioavailability of synthetic and natural ascorbic acid | Q69736839 | ||
| Interaction between effects of beta blockade and cigarette smoke on airways | Q69748410 | ||
| Effect of cannabis on pentobarbital-induced sleeping time and pentobarbital metabolism in the rat | Q69752484 | ||
| Effect of analgesics and exposure to cigarette smoke on the metabolism of acetophenetidin by rat tissues | Q70007056 | ||
| Simplified colorimetric determination of thiocyanate in biological fluids, and its application to investigation of the toxic amblyopias | Q70434909 | ||
| Survey of adolescent drug use. 3. Correlations among use of drugs | Q70448591 | ||
| Smoking and warfarin dosage | Q70504408 | ||
| Meperidine kinetics in man; Intravenous injection in surgical patients and volunteers | Q52719773 | ||
| Smoking and clinical drug effects. | Q52721981 | ||
| Inhibition of drug metabolism in man. | Q52732239 | ||
| Smoking and the anesthetic risk | Q52747081 | ||
| Contribution of cigarette smoking to cadmium accumulation in man. | Q52993743 | ||
| Smoking and drug consumption in white, black, and oriental men and women. | Q53698497 | ||
| Protein binding of benz[a]anthracene and benzo[a]pyrene. | Q53757255 | ||
| Effects of enzyme induction on intestinal phenacetin metabolism in the rat. | Q53763075 | ||
| Cigarette smoke: Stimulatory effect on metabolism of 3,4-benzpyrene by enzymes in rat lung | Q53805880 | ||
| The relationships between smoking and levels of serum urea and uric acid. Results of an epidemiological survey. | Q53851116 | ||
| Nitrosamines in Cigarette Smoke Condensate | Q53917958 | ||
| Inducibility of benzo( )pyrene hydroxylase in human skin by polycylic hydrocarbons. | Q54200358 | ||
| Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. | Q54216734 | ||
| Significance of Smoking in Investigations of Urinary Excretion Rates of Amines in Man | Q58972543 | ||
| Cigarette Smoking and Plasma Levels of Nicotine | Q59072700 | ||
| Enzyme Induction in Man caused by Smoking | Q59099024 | ||
| Pharmacodynamics of imipramine in depressed patients | Q66903660 | ||
| Cadmium potentiation of drug response—Role of the liver | Q66921305 | ||
| Elimination of antipyrine from saliva as a measure of metabolism in man | Q67273613 | ||
| Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking | Q67273626 | ||
| Clinical toxocity of theophylline in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program | Q67290063 | ||
| Induction of aryl hydrocarbon hydroxylase in rat lung by marijuana smoke | Q67319197 | ||
| Smoking and disease: the evidence reviewed | Q67334471 | ||
| Failure of Vitamin C to Affect the Pharmacokinetic Profile of Antipyrine in Man | Q67444709 | ||
| In vivo and in vitro effects of Δ9-tetrahydrocannabinol on rat liver microsomal drug-metabolizing enzymes | Q67446662 | ||
| Enhanced drug metabolism in cigarette smokers | Q67461550 | ||
| Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect | Q67462261 | ||
| Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytes | Q67462288 | ||
| Influence of cannabidiol on secobarbital effects and plasma kinetics | Q67496526 | ||
| Cigarette smoke as a source of pesticide exposure | Q67508681 | ||
| Variable effects of cigarette smoking on aryl hydrocarbon hydroxylase, epodixe hydratase and UDP-glucuronosyltransferase activities in rat lung, kidney and small intestinal mucosa | Q67528362 | ||
| Identification of polynuclear aromatic hydrocarbons in cigarette smoke and their importance as tumorigens | Q67530415 | ||
| Smoke composition. An extensive investigation of the water-soluble portion of cigarette smoke | Q34729810 | ||
| The influence of cigarette smoking and sex on theophylline disposition | Q34734586 | ||
| Acetonitrile in body fluids related to smoking | Q35882500 | ||
| Polonium 210 in tobacco, cigarette smoke, and selected human organs | Q35892478 | ||
| Regulation of drug metabolism in man by environmental chemicals and diet. | Q38565863 | ||
| Nature and fate of insecticide residues inhaled by rats in cigarette smoke | Q39067621 | ||
| Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat | Q39107630 | ||
| Modification of the noradrenaline related effects of smoking by beta-blockade | Q39128818 | ||
| Atmospheric pollution and pentazocine metabolism | Q39319053 | ||
| Cyanide, smoking, and tobacco amblyopia | Q39742104 | ||
| Effects of environmental chemicals on the metabolism of drugs, carcinogens, and normal body constituents in man. | Q39866798 | ||
| Smoking and the gastrointestinal tract | Q39918602 | ||
| The Role of Ascorbic Acid in Drug Metabolism | Q39936074 | ||
| Modification by cyanide of the aniline-binding reaction with cytochrome P-450 | Q39982780 | ||
| Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism | Q39991866 | ||
| Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone | Q40308588 | ||
| Properties, inducibility, and an improved method of analysis of aryl hydrocarbon hydroxylase in cultured human lymphocytes | Q40311623 | ||
| Antipyrine metabolism and bronchogenic carcinoma | Q40489100 | ||
| Trace elements and drug metabolism. | Q40526628 | ||
| Pharmacology of marijuana | Q40695285 | ||
| Induction of the drug-metabolizing enzymes | Q40700623 | ||
| Effect of Aroclor 1254, phenobarbital, and polycyclic aromatic hydrocarbons on the plasma clearance of caffeine in the rat | Q41328124 | ||
| Drowsiness due to chlorpromazine in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program | Q42236062 | ||
| The effects of some tobacco smoke constituents on foreign compound metabolism in the cat and the rat | Q43483454 | ||
| The effect of smoking on nicotine metabolism in vivo in man. | Q43498533 | ||
| Effect of propranolol on blood pressure and skin blood flow during cigarette smoking | Q43527261 | ||
| Nicotine Inhibition of the Metabolism of 3,4-Benzopyrene, a Carcinogen in Tobacco Smoke | Q43595089 | ||
| Letter: Maternal smoking and neonatal hyperbilirubinaemia | Q43675535 | ||
| Distribution of aryl hydrocarbon hydroxylase inducibility in cultured human lymphocytes | Q44197925 | ||
| Biliary excretion of drugs: role of ligandin in newborn immaturity and in the action of microsomal enzyme inducers | Q44280400 | ||
| Comparative metabolism of benzo[a]pyrene and drugs in human liver | Q44594639 | ||
| Metabolic disposition of antipyrine in patients with lung cancer | Q44634126 | ||
| Decreased Concentration of Phenacetin in Plasma of Cigarette Smokers | Q44930867 | ||
| Vitamin C and cigarette smokers | Q45277634 | ||
| Smoking Habits and Pain Tolerance | Q45978974 | ||
| Effects of pesticides on drug and steroid metabolism. | Q46591368 | ||
| Cadmium inhibition of hepatic drug metabolism in the rat. | Q47844573 | ||
| Oxygenation during inhibition of drug metabolism by carbon monoxide or hypoxic hypoxia | Q47957414 | ||
| Effect of delta-9 tetrahydrocannabinol (marihuana) on liver microsomal dechlorinase activity: a preliminary report | Q48025300 | ||
| Comparison of the effect of carbon monoxide and of hypoxic hypoxia. I. In vivo metabolism, distribution and action of hexobarbital | Q48359877 | ||
| Theophylline metabolism by the rat liver microsomal system | Q48410519 | ||
| Clinical Depression of the Central Nervous System Due to Diazepam and Chlordiazepoxide in Relation to Cigarette Smoking and Age | Q48682072 | ||
| Effects of smoking on metabolism and excretion of vitamin B12. | Q49237190 | ||
| Glutethimide and 4-OH glutethimide: pharmacokinetics and effect on performance in man | Q50850209 | ||
| Cigarette smoking and plasma nortriptyline levels | Q51053630 | ||
| Pharmacological implications of microsomal enzyme induction. | Q52474261 | ||
| Biliary flow after microsomal enzyme induction. | Q52474574 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| tobacco smoking | Q7212330 | ||
| P304 | page(s) | 7-39 | |
| P577 | publication date | 1978-02-01 | |
| P1433 | published in | Journal of Pharmacokinetics and Pharmacodynamics | Q15766045 |
| P1476 | title | Role of tobacco smoking in pharmacokinetics | |
| P478 | volume | 6 |
| Q35217493 | A review and assessment of potential sources of ethnic differences in drug responsiveness |
| Q34448073 | Antipyrine clearance and metabolism in patients with psoriasis |
| Q70710448 | Antipyrine clearance in patients with Gilbert's syndrome |
| Q71684336 | Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study |
| Q69962071 | Buprenorphine effects on cigarette smoking |
| Q50848459 | Child and adolescent psychopharmacology. Important developmental issues. |
| Q40952943 | Cigarette smoking and clinically significant drug interactions |
| Q42028459 | Cigarette smoking enhances the elimination of quinine |
| Q69124405 | Circadian changes in the pharmacokinetics of oral ketoprofen |
| Q40084496 | Clinical Implications of Enzyme Induction and Enzyme Inhibition |
| Q39758588 | Clinical Pharmacokinetics of Theophylline |
| Q66986280 | Clinical implications of Surgeon General's Report on Smoking and Health |
| Q39463386 | Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update |
| Q39757950 | Clinical pharmacokinetics of nicotine |
| Q49160897 | Coffee consumption, cigarette smoking and reporting of drowsiness in anxious patients treated with benzodiazepines or placebo |
| Q40088779 | Combination Bronchodilator Therapy |
| Q69940658 | Comparison of the phenacetin and aminopyrine breath tests: effect of liver disease, inducers and cobaltous chloride |
| Q42021525 | Differential effects of enzyme induction on antipyrine metabolite formation |
| Q34527457 | Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man? |
| Q40147811 | Drug metabolism in the elderly: confounding of age, smoking, and ethanol effects |
| Q70767376 | Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics |
| Q34513078 | Effects of tobacco smoking and oral contraceptive use on theophylline disposition |
| Q41987008 | Enzyme induction and beta-adrenergic receptor blocking drugs |
| Q33656679 | Epidemiology, outcomes research, and drug interactions |
| Q40876700 | Ethnicity and antipsychotic response |
| Q33834884 | Gender differences in depression and antidepressant pharmacokinetics and adverse events |
| Q38018026 | Hepatic drug metabolism and aging |
| Q40791116 | Individual variation in first-pass metabolism |
| Q69589898 | Induction of cytochrome P-448 iso-enzymes and related glucuronyltransferases in the human liver by cigarette smoking |
| Q34514212 | Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450. |
| Q39808606 | Influence of Cigarette Smoking on Drug Metabolism in Man |
| Q40287706 | Influence of age and smoking on drug kinetics in man: studies using model compounds |
| Q40467542 | Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation. |
| Q51800299 | Influence of propranolol coadministration or cigarette smoking on the kinetics of desmethyldiazepam following intravenous clorazepate. |
| Q68687377 | Influence of smoking and gender on the disposition kinetics of metoprolol |
| Q67650366 | Influence of standard and nicotine-reduced cigarette smoke on plasma concentrations of isosorbide dinitrate and its metabolites in rats |
| Q67834977 | Influences of long-term cigarette smoke exposure on pharmacokinetics of theophylline, and on liver microsomal enzymes in rats |
| Q43228961 | Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients |
| Q43228889 | Lack of influence of cigarette smoking on triazolam pharmacokinetics |
| Q33630080 | Medication and the elderly. Issues of prescription and use. |
| Q37238140 | Metabolism of nicotine |
| Q42835363 | Modification of propranolol's bioavailability by Eurycoma longifolia water-based extract |
| Q72561847 | Pharmacokinetics and absolute bioavailability of carteolol, a new ?-adrenergic receptor blocking agent |
| Q51871282 | Pharmacokinetics of N-desmethyldiazepam after a single oral dose of clorazepate: The effect of smoking |
| Q41619443 | Pharmacokinetics of drug interactions |
| Q38688263 | Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics |
| Q21245066 | Role of cytochrome P450 in drug interactions |
| Q39286779 | Role of the lung in total body clearance of circulating drugs |
| Q69393487 | Sex-related differences in theophylline pharmacokinetics |
| Q39850162 | The application of clearance concepts to propranolol disposition in man. |
| Q48940778 | The effect of a single treatment with cigarette smoke on the blood levels and hemodynamic effects of propranolol in rats. |
| Q34447852 | The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies |
| Q68449469 | The effect of cigarette smoking on drug metabolism in the liver and placenta: the use of cotinine in verifying smoking status |
| Q44747787 | The effect of the 4-quinolone enoxacin on plasma theophylline concentrations |
| Q34446722 | The influence of age and smoking on the elimination of disopyramide |
| Q51870849 | The relationships between clinical response, psychophysiological variables and plasma levels of amitriptyline and diazepam in neurotic outpatients. |
| Q43243670 | Theophylline kinetics in relation to age: the importance of smoking |
| Q35733010 | Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial |
| Q40999769 | beta-blockers. Drug interactions of clinical significance |
Search more.